Ozempic Cost 2026: Prices, Insurance & Alternatives

As of October 8, 2026, Ozempic costs $349 a month without insurance for the 0.25, 0.5 or 1 mg pen and $499 for the 2 mg pen (Ozempic savings page). Its list price is $1,027.51 per pen (NovoCare). With commercial coverage, Novo’s savings offer can bring a fill to $25 (offer terms).

How much does Ozempic cost without insurance?

Quick answer: $349 a month for the 0.25, 0.5 or 1 mg pen and $499 for the 2 mg pen on Novo Nordisk’s self-pay offer, as of October 8, 2026.

As checked October 8, 2026, Novo Nordisk advertises $199 for each of the first two monthly fills of the 0.25 or 0.5 mg starting doses for eligible new patients, with fills through December 31, 2026. Ongoing prices are $349 for 0.25, 0.5 or 1 mg and $499 for 2 mg. The manufacturer defines a month as one box containing one pen. Eligibility and changeable terms apply; this is not a price promise for every prescription. Source: Ozempic manufacturer savings terms

Ozempic option	Price	Conditions	Source
Pen 0.25 or 0.5 mg, first two fills	$199	New patients only; per pen (one month); through December 31, 2026	Ozempic savings page
Pen 0.25, 0.5 or 1 mg, self-pay	$349	Per pen (one month)	Ozempic savings page
Pen 2 mg, self-pay	$499	Per pen (one month)	Ozempic savings page
Tablets 1.5 / 4 / 9 mg, self-pay	$149 / $199 / $299	Per bottle of 30 tablets	NovoCare offer terms
Costco member price, pen 0.25 / 0.5 mg	$199	Costco members, cash; Costco limits this price to 2 fills	Costco price search
GoodRx coupon, as low as	$149	The 1.5 mg tablet; GoodRx does not show a pharmacy or location	GoodRx
With commercial coverage (savings offer)	$25	Pay as little as, per 1-, 2- or 3-month fill; savings capped; no government plans	NovoCare offer terms
List price	$1,027.51	Per pen, before discounts and rebates	NovoCare

All figures checked October 8, 2026. Budget on the ongoing price for the dose you are likely to stay on, not on the first two fills.

How much does Ozempic cost with insurance?

Quick answer: It depends on your plan. With commercial coverage, Novo’s savings offer can bring a fill to as little as $25; government plans cannot use it.

Coverage depends on the drug, diagnosis, plan formulary and prior authorization. Ask about the cost after your deductible and any required clinical documentation. Commercial savings and self-pay offers have different rules. Medicare GLP-1 Bridge is a temporary program for certain eligible beneficiaries beginning in July 2026; it does not mean automatic coverage for everyone. CMS: Medicare GLP-1 Bridge eligibility

Will Ozempic’s price change in 2027?

Quick answer: Its list price drops to $675 a month on January 1, 2027, Novo Nordisk says, but self-pay prices do not change.

Novo Nordisk announced on February 24, 2026, a $675 monthly list price for Ozempic, Wegovy and Rybelsus from January 1, 2027, aimed at patients whose out-of-pocket cost is tied to list price, such as during a deductible. It says direct-to-patient self-pay prices are not affected. Source: Novo Nordisk news release

What do REMEVi plans cost, and how are they billed?

Quick answer: REMEVi bills every four weeks, not by calendar month, and the 12- and 24-week plans are paid upfront. These are compounded preparations, not Ozempic.

REMEVi prices use four-week billing periods, which are not calendar months. The 12- and 24-week terms require the full total upfront. Lab work that the clinician requires for treatment is included.

Compounded preparation	Every 4 weeks	12 weeks: total upfront	24 weeks: total upfront
Injectable semaglutide	$199	$507 ($169/4 weeks)	$954 ($159/4 weeks)
Injectable tirzepatide	$269	$699 ($233/4 weeks)	$1,350 ($225/4 weeks)
Compounded oral semaglutide	$249	$687 ($229/4 weeks)	$1,290 ($215/4 weeks)

See current semaglutide and tirzepatide plan details. Compounded oral semaglutide is not an approved Wegovy, Ozempic or Rybelsus tablet. Eligibility and prescribing depend on clinical evaluation. Service is available in 49 states and Washington, DC, excluding Louisiana.

Is compounded semaglutide FDA-approved?

Quick answer: No. Compounded preparations are not FDA-approved, are not generics of Ozempic or any brand, and have no established clinical equivalence to them.

Compounded preparations are not FDA-approved, are not generics of the brands and do not have established clinical equivalence to them. FDA recommends their use only when an available approved product cannot meet the medical need. A lower price does not establish equal safety or effectiveness. Source: FDA: unapproved GLP-1 medicines

What should I check before choosing?

Quick answer: The product, route, pharmacy, supply length, full upfront payment, refill terms and cancellation policy — and who handles side effects.

Confirm the product, route, pharmacy, supply length, full upfront payment, refill terms and cancellation policy. Ask who handles side effects and what happens if clinical review does not recommend treatment. Review care options.